Lasmiditan (200 Mg and 100 Mg) Compared to Placebo for Acute Treatment of Migraine

被引：0
|
作者：
Kuca, B. [1 ]
Wietecha, L. [2 ]
Berg, P. [2 ]
Aurora, S. K. [2 ]
机构：
[1] CoLucid Pharmaceut Inc, Cambridge, MA USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
HEADACHE | 2017年 / 57卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IOR-11LB
引用
收藏
页码：1311 / 1312
页数：2
相关论文
共 50 条
  • [11] Comparing the safety, efficacy and tolerability of lasmiditan 100 mg and 200 mg in acute migraine treatment: a systematic review, meta-analysis and meta-regression of randomized controlled trials
    Cyntia Lima Fonseca Rodrigues, A.
    Kraychete, B.
    Castro Olyntho, M. A., Jr.
    Miranda Figueredo, J.
    Botelho Lorenzo, V.
    Ferreira Pereira, L.
    Turatti Miranda, R.
    Cruz Majdalani, V.
    Bernardo Lanca, S.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [12] Phase-3 study (SPARTAN) of Lasmiditan compared to placebo for acute treatment of migraine
    Wietecha, L. A.
    Kuca, B.
    Case, M. G.
    Selzler, K. J.
    Aurora, S. K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 79 - 79
  • [13] Lasmiditan for the acute treatment of migraine
    DeJulio, Paul A.
    Perese, Joshua K.
    Schuster, Nathaniel M.
    Oswald, Jessica C.
    PAIN MANAGEMENT, 2021, 11 (05) : 437 - 449
  • [14] Lasmiditan for the acute treatment of migraine
    Tepper, Deborah
    HEADACHE, 2020, 60 (06): : 1225 - 1226
  • [15] DANAZOL IN THE TREATMENT OF MENORRHAGIA - THE EFFECT OF A 1 MONTH INDUCTION DOSE (200 MG) AND 2 MONTHS MAINTENANCE THERAPY (200 MG, 100 MG, 50 MG OR PLACEBO)
    NEED, JA
    FORBES, KL
    MILAZZO, L
    MCKENZIE, E
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1992, 32 (04): : 346 - 352
  • [16] Lasmiditan for acute migraine treatment
    Neeb, Lars
    Reuter, Uwe
    FUTURE NEUROLOGY, 2013, 8 (06) : 631 - 638
  • [17] Lasmiditan for acute treatment of migraine
    Parikh, S.
    DRUGS OF TODAY, 2021, 57 (02) : 89 - 100
  • [18] ANALGESIC EFFICACY OF KETOPROFEN 25 MG AND 100 MG COMPARED TO IBUPROFEN 400 MG AND PLACEBO
    COOPER, S
    BERRIE, R
    COHN, P
    JOURNAL OF DENTAL RESEARCH, 1986, 65 : 275 - 275
  • [19] Clinical measures of efficacy, safety and tolerability for the acute treatment of migraine: A comparison of eletriptan (20-80 mg), sumatriptan (100 mg) and placebo
    Jackson, NC
    NEUROLOGY, 1998, 50 (04) : A376 - A376
  • [20] A cost-effectiveness analysis of eletriptan 40 mg and 80 mg versus sumatriptan 50 mg and 100 mg in the acute treatment of migraine
    Wells, NEJ
    Drummond, MF
    VALUE IN HEALTH, 2003, 6 (06) : 764 - 764
12345